AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations

RecruitingNAAges 18 Years - 60 YearsAllUniversity Hospital, Lille
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The INTRUDE trial aims at assessing the efficacy of an fMRI-based neurofeedback procedure on drug-resistant auditory hallucinations. Hallucinations are complex and transient mental states associated with subtle and brain-wide patterns of activity for which we were recently able to validate an fMRI multivariate decoder. Based on this progress, we can track patients' hallucinatory status using real-time fMRI. We will test whether schizophrenia patients with drug-resistant hallucinations can be trained to maintain the brain state associated with a no-hallucination condition using appropriate strategies and thus reduce overall severity. We will refer to a double-blind randomized placebo-controlled design. A total of 86 patients will be enrolled and equally split in an active neurofeedback group (n=43) and a sham group (n=43), matched for sex, age and PANSS scores. Each patient will benefit f

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Right-handed female/male between 18 to 60 y.o. * Schizophrenia (according to the DSM-5 classification) * Frequent auditory hallucinations (SAPS item #1 โ‰ฅ 4) * Stable medication for at least 30 days * Absence of chronic neurological disorder (including seizure) * Able to provide free written consent to participate in the research Exclusion Criteria: * Refusal to participate after clear and honest information about the study has been provided * Clinical condition incompatible with the study protocol (e.g. agitation, severe disorganization, catatonia) * Pregnancy * Contraindication to MRI scan: pacemaker, ferromagnetic vascular clip, ferromagnetic foreign body * Morphological criteria: weight \>130kg, abdominal cirumference exceeding magnet aperture, shoulder width * Claustrophobia * Refusal to be informed of any incidental findings observed during the MRNI * No social insurance
๐Ÿ’Š

What it tests

  • Active neurofeedback procedure
  • Sham neurofeedback procedure
๐Ÿ“

Where

1 site
Hop Fontan Chu
Lille, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy